|Bid||0.00 x 1100|
|Ask||170.70 x 800|
|Day's Range||169.73 - 171.12|
|52 Week Range||155.72 - 186.69|
|Beta (5Y Monthly)||0.59|
|PE Ratio (TTM)||24.77|
|Earnings Date||Oct 18, 2022|
|Forward Dividend & Yield||4.52 (2.66%)|
|Ex-Dividend Date||Aug 22, 2022|
|1y Target Est||187.84|
Subscribe to Yahoo Finance Plus to view Fair Value for JNJ
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett has, arguably, cemented himself among the investing greats. In the 57 years he's held the reins at Berkshire, he's led his company's Class A shares (BRK.A) to an aggregate return of a scorching 3,641,613%, through Dec. 31, 2021. The Oracle of Omaha's company has outperformed the broad-based S&P 500 by so much that it's share price could fall 99% tomorrow and it would still be handily outpacing the S&P 500 since 1965.
NEW BRUNSWICK, N.J., August 09, 2022--Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14th, at the Sheraton New York Hotel in New York. Joaquin Duato, Chief Executive Officer, and Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 11:10 a.m. (Eastern Time).
The pair of health care giants will work to improve health equity, better support nurses and enhance patient care.